Compound information
- Natural Products
- ZC415741
- Molecular Formula
- C15H22N4O4
- Molecular Weight
- 322.164105184 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-(benzyloxycarbonylamino)-6-guanidino-hexanoic acid
- InChI
- InChI=1S/C15H22N4O4/c16-14(17)18-9-5-4-8-12(13(20)21)19-15(22)23-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10H2,(H,19,22)(H,20,21)(H4,16,17,18)/t12-/m0/s1
- InChI Key
- KTPKIMJAZDFELN-LBPRGKRZSA-N
- SMILES
- N=C(N)NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000031829399
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 137.53 Å2 | LogP | 0.161 |
LogS | -2.765 | LogD | -0.209 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.263 |
HIA | 0.003 | F20 % | 0.786 |
F30 % | 0.001 | Caco-2 | -6.625 |
MDCK | -5.786 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.871 | PPB | 60.85 |
VD | 0.251 | Fu | 0.144 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.686 |
CYP2A6 substrate | 0.408 | CYP2B6 substrate | 0.511 |
CYP2C19 inhibitor | 0.131 | CYP2C19 substrate | 0.81 |
CYP2C8 substrate | 0.674 | CYP2C9 inhibitor | 0.226 |
CYP2C9 substrate | 0.349 | CYP2D6 inhibitor | 0.149 |
CYP2D6 substrate | 0.679 | CYP2E1 substrate | 0.23 |
CYP3A4 inhibitor | 0.015 | CYP3A4 substrate | 0.524 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.668 | CL | 4.258 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.482 | Hepatotoxicity | 0.053 |
Mutagenicity | 0.01 | Rat Oral Acute Toxicity | 0.04 |
FDAMDD | 0.066 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.005 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.095 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.397 | IGC50 | 1.825 |
LC50FM | 3.394 | LC50DM | 4.741 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.256 | NR-AR-LBD | 0.266 |
NR-AhR | 0.003 | NR-Aromatase | 0.025 |
NR-ER | 0.326 | NR-ER-LBD | 0.347 |
NR-PPAR-gamma | 0.505 | SR-ARE | 0.074 |
SR-ATAD5 | 0.329 | SR-HSE | 0.114 |
SR-MMP | 0.009 | SR-p53 | 0.02 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.